Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osheroff

Showing results (171-180 of 362) with videos related to

Pageof 37
Sort By:
Biochemistry|December 21, 2012
Oxidative metabolites of curcumin poison human type II topoisomerasesAdam C Ketron, Odaine N Gordon, Claus Schneider, et al.
The Journal of Biological Chemistry|June 7, 2002
Human topoisomerase IIalpha possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5' covalently activated oligonucleotide substrates to study enzyme mechanismKenneth D Bromberg, Chris Hendricks, Alex B Burgin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1979
Definition of cytochrome c binding domains by chemical modification: kinetics of reaction with beef mitochondrial reductase and functional organization of the respiratory chainS H Speck, S Ferguson-Miller, N Osheroff, et al.
ACS Infectious Diseases|February 14, 2019
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus GyraseElizabeth G Gibson, Ben Bax, Pan F Chan, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2019
6,6'-Dihydroxythiobinupharidine as a poison of human type II topoisomerasesEsha D Dalvie, Jacob Gopas, Avi Golan-Goldhirsh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classesN Osheroff, A H Corbett, S H Elsea, et al.
Plos One|April 7, 2010
Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidyYang Wang, Robert J Coffey, Neil Osheroff, et al.
Biochemistry|February 7, 2012
Amsacrine as a topoisomerase II poison: importance of drug-DNA interactionsAdam C Ketron, William A Denny, David E Graves, et al.
Biochemistry|June 9, 2004
1,4-Benzoquinone is a topoisomerase II poisonR Hunter Lindsey, Kenneth D Bromberg, Carolyn A Felix, et al.
The Journal of Biological Chemistry|October 15, 1991
Inhibition of eukaryotic topoisomerase II by ultraviolet-induced cyclobutane pyrimidine dimersA H Corbett, E L Zechiedrich, R S Lloyd, et al.
Pageof 37

Showing results (171-180 of 362) with videos related to

Sort By:
Pageof 37
Biochemistry|December 21, 2012
Oxidative metabolites of curcumin poison human type II topoisomerasesAdam C Ketron, Odaine N Gordon, Claus Schneider, et al.
The Journal of Biological Chemistry|June 7, 2002
Human topoisomerase IIalpha possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5' covalently activated oligonucleotide substrates to study enzyme mechanismKenneth D Bromberg, Chris Hendricks, Alex B Burgin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1979
Definition of cytochrome c binding domains by chemical modification: kinetics of reaction with beef mitochondrial reductase and functional organization of the respiratory chainS H Speck, S Ferguson-Miller, N Osheroff, et al.
ACS Infectious Diseases|February 14, 2019
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus GyraseElizabeth G Gibson, Ben Bax, Pan F Chan, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2019
6,6'-Dihydroxythiobinupharidine as a poison of human type II topoisomerasesEsha D Dalvie, Jacob Gopas, Avi Golan-Goldhirsh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classesN Osheroff, A H Corbett, S H Elsea, et al.
Plos One|April 7, 2010
Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidyYang Wang, Robert J Coffey, Neil Osheroff, et al.
Biochemistry|February 7, 2012
Amsacrine as a topoisomerase II poison: importance of drug-DNA interactionsAdam C Ketron, William A Denny, David E Graves, et al.
Biochemistry|June 9, 2004
1,4-Benzoquinone is a topoisomerase II poisonR Hunter Lindsey, Kenneth D Bromberg, Carolyn A Felix, et al.
The Journal of Biological Chemistry|October 15, 1991
Inhibition of eukaryotic topoisomerase II by ultraviolet-induced cyclobutane pyrimidine dimersA H Corbett, E L Zechiedrich, R S Lloyd, et al.
Pageof 37